Barts Health NHS Trust ( Site 0401)

London, London, City of E1 1RD

1 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer Recurrent

Studies at this site

• A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) — Recruiting now